The Biosimilar Was Too Cheap to Sell. So the Price Went Up Fourfold.
Byooviz relaunched in the US at an average sales price of $1,190, roughly four times its previous level and above the originator it references.
Samsung Bioepis
Byooviz relaunched in the US at an average sales price of $1,190, roughly four times its previous level and above the originator it references.